Exploiting p53-dependent functional duality of estrogen receptor-beta to repurpose tamoxifen for triple negative breast cancer therapyCANCER RESEARCHIF16.62020-02-150PRE
TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast CancerJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTEIF7.22019-04-1637OAAI
p53 status as a determinant of functional duality of estrogen receptor beta in breast cancer: Therapeutic implicationsCANCER RESEARCHIF16.62018-07-010PRE
p53 status as a determinant of estrogen receptor beta function in breast cancerCANCER RESEARCHIF16.62015-08-013PRE
The BH3-only protein, Noxa, is upregulated by estrogen and promotes cell cycle progression in estrogen receptor-positive breast cancer cellsCANCER RESEARCHIF16.62012-04-010PRE
Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulationPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12010-08-09116OAAI